Role of systemic treatment in adult soft tissue sarcomas

European Journal of Cancer, Supplement

Volumn 1, Issue 6 SPEC. ISS., 2003, Pages 249-259

  Nielsen, Ole S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CARUBICIN; CHLOROZOTOCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; EXATECAN; FOTEMUSTINE; GEFITINIB; GEMCITABINE; IFOSFAMIDE; IMATINIB; METHOTREXATE; MILTEFOSINE; MITOGUAZONE; MITOMYCIN; MITOXANTRONE; MITOZOLOMIDE; NIMUSTINE; PACLITAXEL; RAZOXANE; SPARFOSIC ACID; TRABECTEDIN; TROFOSFAMIDE; UNINDEXED DRUG;

ALOPECIA; ANGIOSARCOMA; BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG FORMULATION; EWING SARCOMA; FATIGUE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LEIOMYOSARCOMA; LIMB PERFUSION; LIVER TOXICITY; LUNG METASTASIS; META ANALYSIS; METASTASIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 5144224155     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6349(03)90029-2     Document Type: Conference Paper

References (30)

1. Brennan M.F., Alektiar K.M., Maki R.G. Soft tissue sarcoma. De Vita V.T., Hellman S., Rosenberg S.A. Cancer Principles & Practice Of Oncology. 6th ed. :2001;1841-1890 Lippincott Williams & Wilkins, Philadelphia
2. Suit H.D., Van Groeningen G.J., Mankin H.J., Rosenberg A.E. Sarcoma of soft tissues. 2nd ed Peckham M., Pinedo H., Veronesi U. Oxford Textbook of Oncology. 1995;1917-1939 Oxford Univ Press, Oxford
3. Nielsen O.S., Blay J.Y., Judson I.R., et al. Metastatic soft tissue sarcoma in adults. Prognosis and treatment options. Am J Cancer. 2:2003;. (in press)
4. Dirix L.Y., van Oosterom A.T. Soft tissue sarcoma in adults. Curr Opin Oncol. 11:1999;285-295
5. Clasby R., Tilling K., Smith M.A., et al. Variable management of soft tissue sarcoma: regional audit with implications for specialist care. Br J Surg. 84:1997;1692-1696
6. O'Sullivan B., Wylie J., Catton C., Gutierrez E., Swallow C.J., Wunder J., et al. The local management of soft tissue sarcoma. Semin Radiat Oncol. 9:1999;328-348
7. Lewis J.J., Leung D., Espat J., Woodruff J.M., Brennan M.F. Effect of reresection in extremity soft tissue sarcoma. Ann Surg. 231:2000;655-663
8. O'Byrne K., Steward W.P. The role of chemotherapy in the treatment of adult soft tissue sarcomas. Oncology. 56:1999;13-23
9. Nielsen O.S., O'Sullivan B. Retroperitoneal soft tissue sarcomas: A treatment challenge and a call for randomised trials. Radiother. 65:2002;133-136
10. van Geel A.N., Pastorino U., Jauch K.W., et al. Surgical treatment of lung metastases. The European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer. 77:1996;675-682
11. Verweij J., Mouridsen H.T., Nielsen O.S., et al. The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view. Critical Rev Oncol/Hematol. 20:1995;193-201
12. Gortzak E., Azzarelli A., Buesa J., et al. A randomised phase II study on neo-Aduvant chemotherapy for "high-risk" adult soft-tissue sarcoma. Eur J Cancer. 37:2001;1096-1103
13. Eilber F.C., Rosen G., Eckardt J., et al. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol. 19:2001;3203-3209
14. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 350:1997;1647-1654
15. Adjuvant chemotherapy for localized resectable soft tissue sarcoma in adults. Cochrane Database Syst Rev. 4:2000;. CD001419.
16. Frustaci S., Gherlinzoni F., De Paoli A., et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 19:2001;1238-1247
17. Nielsen O.S., Dombernowsky P., Mouridsen H., et al. Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC Soft Tissue And Bone Sarcoma Group. Sarcoma. 4:2000;31-35
18. Bramwell V.H.C., Anderson D., Charette M.L., et al. Doxorubicin-based chemotherapy for palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline. Sarcoma. 4:2000;103-112
19. Judson I., Radford J.A., Harris M., et al. Randomized phase II trial of pegylated liposomal doxorubicin (Doxil®/Caelyx®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer. 37:2001;870-877
20. Delaloge S., Yovine A., Taamma A., et al. Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients - preliminary evidence of activity. J Clin Oncol. 19:2001;1248-1255
21. Santoro A., Tursz T., Mouridsen H., et al. Doxorubicin versus CyVADIC versus ifosfamide plus doxorubicin in first line treatment of advanced soft tissue sarcomas. A randomized study of the EORTC Soft Tissue And Bone Sarcoma Group. J Clin Oncol. 13:1995;1537-1545
22. Patel S., Vadhan-Raj S., Burgess M.A., et al. Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol. 21:1998;317-321
23. Reichardt P., Tilgner J., Hohenberger P., et al. Dose-intensive chemotherapy with ifosfamide, epirubicin and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study. J Clin Oncol. 16:1998;1438-1443
24. Leyvraz S., Bacchi M., Cerny T., et al. Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas, Swiss Group for Clinical Research (SAKK). Ann Oncol. 9:1998;877-884
25. Blay J.-Y., Bouhour D., Ray-Coquard I., et al. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults. J Clin Oncol. 18:2000;3643-3650
26. Van Oosterom A.T., Judson I., Verweij J., et al. Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumors: a phase I study. Lancet. 358:2001;1421-1423
27. Demetri G.D., von Mehren M., Blanke C.D., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 347:2002;472-480
28. Van Glabbeke M., van Oosterom A.T., Oosterhuis J.W., et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcomas: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens - a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol. 17:1999;150-157
29. Billingsley K.G., Lewis J.J., Leung D.H., et al. Multifactorial analysis of the survival of patients with distant metastases arising from primary extremity sarcoma. Cancer. 85:(2):1999;389-395
30. Levine E.A., Holzmayer T., Bacus S., et al. Evaluation of newer prognostic markers for adult soft tissue sarcomas. J Clin Oncol. 15:1997;3249-3257